{"filing":{"accession_number":"0001104659-26-072343","cik":"0001083446","ticker":"ASTH","company_name":"Astrana Health, Inc.","form":"8-K","filing_date":"2026-06-10","report_date":null,"primary_document":"tm2614755d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465926072343/tm2614755d1_8k.htm"},"events":[{"id":5604,"run_id":4916,"accession_number":"0001104659-26-072343","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Astrana Health held its Annual Meeting on June 10, 2026, with shareholders voting on four proposals: election of nine directors, ratification of Ernst \u0026 Young LLP as independent auditor, advisory approval of executive compensation, and approval of the amended 2024 equity incentive plan. The filing discloses detailed vote tallies for all proposals.","company_name":"Astrana Health, Inc.","ticker":"ASTH","filing_date":"2026-06-10","form":"8-K","submitted_at":null,"items":[{"id":5874,"accession_number":"0001104659-26-072343","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an amended and restated equity incentive plan with material modifications: an increase of 1,000,000 shares reserved for issuance and an extension of the plan term to March 24, 2036. This is a compensatory arrangement disclosure under Item 5.02(e), as it involves shareholder approval of a material equity plan amendment affecting executive and employee compensation eligibility and potential dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T20:17:52.128149+00:00","company_name":"","ticker":null,"filing_date":""},{"id":5875,"accession_number":"0001104659-26-072343","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Astrana Health's Annual Meeting held on June 10, 2026. The filing presents detailed vote tallies for four proposals: election of nine directors, ratification of Ernst \u0026 Young LLP as independent auditor, advisory approval of executive compensation, and approval of the 2024 Plan. This is the quintessential Item 5.07 disclosure and is material to investors as it documents the outcomes of key governance and compensation matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T20:17:52.128149+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5874,"accession_number":"0001104659-26-072343","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an amended and restated equity incentive plan with material modifications: an increase of 1,000,000 shares reserved for issuance and an extension of the plan term to March 24, 2036. This is a compensatory arrangement disclosure under Item 5.02(e), as it involves shareholder approval of a material equity plan amendment affecting executive and employee compensation eligibility and potential dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T20:17:52.128149+00:00","company_name":"Astrana Health, Inc.","ticker":"ASTH","filing_date":"2026-06-10"},{"id":5875,"accession_number":"0001104659-26-072343","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Astrana Health's Annual Meeting held on June 10, 2026. The filing presents detailed vote tallies for four proposals: election of nine directors, ratification of Ernst \u0026 Young LLP as independent auditor, advisory approval of executive compensation, and approval of the 2024 Plan. This is the quintessential Item 5.07 disclosure and is material to investors as it documents the outcomes of key governance and compensation matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T20:17:52.128149+00:00","company_name":"Astrana Health, Inc.","ticker":"ASTH","filing_date":"2026-06-10"}]}